'Complete trial on adults first': Government panel says no to Covovax trial by Serum Institute of India
The SII has applied to the Drugs Controller General of India (DCGI) on Monday seeking permission for conducting a trial of Covovax on 920 children, 460 each in the 12-17 and 2-11 age groups, at 10 sites.
Jul 01, 2021, 09:33 AM IST
Covovax vaccine will be ready to launch in India by September, says SII
SII also said that they are planning to start clinical trials of Covovax for children from the next month.
Jun 16, 2021, 15:26 PM IST
Serum Institute of India applies to DCGI to manufacture Sputnik V COVID vaccine, seeks indemnity
Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their COVID-19 jabs in India, the SII has also sought protection against liabilities.
Jun 03, 2021, 12:32 PM IST
Government panel recommends 12-16 week gap between Covishield doses, no change for Covaxin
The recommendations were made by the National Technical Advisory Group on Immunisation (NTAGI) which suggested increasing the gap between two doses of Serum Institute of India`s COVISHIELD to 12-16 weeks.
May 13, 2021, 13:36 PM IST
Serum Institute working closely with govt, received all kinds of support: Adar Poonawalla
The statement from India's COVID-19 vaccine maker Adar Poonawalla comes at a time when he alleged during an exclusive interview with 'Times' that he ad been receiving threats in India and that he and his family left the country for London after unprecedented "pressure and aggression" over the demand of vaccines.
May 03, 2021, 16:57 PM IST
Powerful Indians making aggressive calls for COVID vaccines: Serum CEO Adar Poonawalla
The Serum Institute chief spoke about receiving aggressive calls from some of the most powerful people in India, demanding supplies of Covishield -- the Oxford/AstraZeneca COVID-19 vaccine that the institute is producing in India.
May 02, 2021, 00:26 AM IST
Bill Gates says COVID vaccine formula should not be shared with India, developing nations, sparks row
Bill Gates has made a controversial statement regarding the patents in vaccine technology and is facing heat from all around
Apr 30, 2021, 12:19 PM IST
Pfizer, AstraZeneca jabs: 1 in 4 suffer mild side effects
One in four people experience mild, short lived systemic side effects like headache, fatigue and tenderness after receiving either the Pfizer or AstraZeneca vaccine, according to a new study published in the journal Lancet Infectious Diseases.
Apr 28, 2021, 13:13 PM IST
In pics: Serum Institute of India fire kills five people; SII announces compensation
Serum Institute of India Pvt Ltd is the world's largest vaccine manufacturer by a number of doses produced and sold globally (more than 1.5 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines, as per the company's website.
Jan 22, 2021, 00:55 AM IST
Serum Institute of India fire: Five people killed, SII offers compensation of Rs 25 lakh to families; PM Narendra Modi condoles lives lost
Serum Institute of India (SII) has offered compensation of Rs 25 lakh in addition to the mandated amount to families of persons who died in a fire at the company's premises in Pune. Five men died after a fire broke out in a five-storeyed under-construction building at the firm's Manjari premises in Pune on Thursday. All were construction workers whose bodies were recovered by fire brigade personnel from the fifth floor..
Jan 21, 2021, 22:59 PM IST
Serum Institute of India fire: Five charred bodies recovered from building, says Pune mayor; Covishield facility not affected
The SII fire broke out where the BCG vaccine is made and the Covishield facility has not been affected, said, officials. So far, nine persons have been evacuated from the building in the SII's Manjari premises. There would be no loss of Covishield production due to the fire, Serum Institute of India CEO Adar Poonawalla said.
Jan 21, 2021, 18:39 PM IST
Massive fire breaks out at Terminal 1 gate of Pune's Serum Institute of India, 10 fire tenders rushed to spot
A massive fire broke out at the Serum Institute of India in Pune, Maharashtra, on Thursday (January 21). At least 10 fire tenders have reached the spot so far.
The fire broke out at Terminal 1 gate of the Manjari facility where the Covishield vaccine is being made. The Covishield vaccine is being used in the national inoculation drive against coronavirus.
Jan 21, 2021, 16:20 PM IST
First consignment of Bharat Biotech`s Covaxin arrives in Delhi for January 16 mass vaccination
On Tuesday, the first consignment of COVID-19 vaccine 'Covishield' had arrived at Delhi's IGIA from Pune
Jan 13, 2021, 11:55 AM IST
SII, Bharat Biotech take joint pledge for 'smooth rollout' of COVID-19 vaccines
SII & Bharat Biotech on Tuesday took a joint pledge for 'smooth rollout' of COVID-19 vaccines. Adar Poonawala is the Chief Executive Officer of SII, while Dr Krishna Ella is Chairman and Managing Director of Bharat Biotech.
Jan 05, 2021, 16:34 PM IST
Big breakthrough! Serum Institute of India develops first indigenous vaccine against pneumonia; launch next week
The vaccine will be much more affordable than existing ones manufactured by two foreign companies. India's drug regulator in July had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the phase 1, 2 and 3 clinical trial data submitted by the Pune-based firm.
Dec 24, 2020, 07:46 AM IST
India requires Rs 80,000 cr for vaccine distribution next year: SII
The Central government plans to vaccinate nearly 30 crore people in the first phase of the drive. It will be offered to one crore healthcare workers, along with two crore frontline and essential workers and 27 crore elderly, mostly above the age of 50 years with comorbidities.
Dec 19, 2020, 13:24 PM IST
COVID-19: After Pfizer, Pune-based SII seeks emergency use approval for Covishield vaccine in India
SII on Sunday applied to the DCGI seeking emergency use authorisation for Oxford-AstraZeneca Covid-19 vaccine in the country.
Dec 07, 2020, 07:58 AM IST
COVID-19: What Centre said about rollout plan of SII vaccine Covishield
The senior government official asserted that the alleged adverse event will not affect the timeline of the vaccine.
Dec 02, 2020, 11:37 AM IST
COVID-19 vaccine: SII CEO Poonawalla makes big announcement after PM Modi visit
SII CEO Adar Poonawalla said that his company will seek permission for emergency use authorization of 'Covishield' in the next two weeks.
Nov 29, 2020, 07:00 AM IST
